BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17369502)

  • 1. Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening.
    Sharif S; Moran A; Huson SM; Iddenden R; Shenton A; Howard E; Evans DG
    J Med Genet; 2007 Aug; 44(8):481-4. PubMed ID: 17369502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
    Ji J; Hemminki K
    Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
    Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
    Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
    Olsen JH; Seersholm N; Boice JD; Krüger Kjaer S; Fraumeni JF
    Br J Cancer; 1999 Feb; 79(3-4):673-9. PubMed ID: 10027348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
    Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Fan I; Tang J; Li S; Zhang S; Shaw PA; Narod SA
    J Natl Cancer Inst; 2006 Dec; 98(23):1694-706. PubMed ID: 17148771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer and other neoplasms in women with neurofibromatosis type 1: a retrospective review of cases in the Detroit metropolitan area.
    Wang X; Levin AM; Smolinski SE; Vigneau FD; Levin NK; Tainsky MA
    Am J Med Genet A; 2012 Dec; 158A(12):3061-4. PubMed ID: 22965642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of breast cancer from screening women according to predicted family history risk: Does annual clinical examination add to mammography?
    Gui GP; Hogben RK; Walsh G; A'Hern R; Eeles R
    Eur J Cancer; 2001 Sep; 37(13):1668-73. PubMed ID: 11527694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study.
    Evans DGR; Kallionpää RA; Clementi M; Trevisson E; Mautner VF; Howell SJ; Lewis L; Zehou O; Peltonen S; Brunello A; Harkness EF; Wolkenstein P; Peltonen J
    Genet Med; 2020 Feb; 22(2):398-406. PubMed ID: 31495828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in invasive breast cancer incidence among French women not exposed to organized mammography screening: an age-period-cohort analysis.
    Viel JF; Rymzhanova R; Fournier E; Danzon A
    Cancer Epidemiol; 2011 Dec; 35(6):521-5. PubMed ID: 21621498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2.
    Domchek SM; Gaudet MM; Stopfer JE; Fleischaut MH; Powers J; Kauff N; Offit K; Nathanson KL; Robson M
    Breast Cancer Res Treat; 2010 Jan; 119(2):409-14. PubMed ID: 19885732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
    Taylor R; Page A; Bampton D; Estoesta J; Rickard M
    J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of invasive breast cancer in the presence of competing mortality: the Canadian National Breast Screening Study.
    Taghipour S; Banjevic D; Fernandes J; Miller AB; Montgomery N; Harvey BJ; Jardine AK
    Breast Cancer Res Treat; 2012 Jul; 134(2):839-51. PubMed ID: 22689090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
    Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
    J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families.
    Harvey SL; Milne RL; McLachlan SA; Friedlander ML; Birch KE; Weideman P; ; Goldgar D; Hopper JL; Phillips KA
    Breast Cancer Res Treat; 2011 Dec; 130(3):1057-61. PubMed ID: 21850394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excess breast cancer risk and the role of parity, age at first childbirth and exposure to radiation in infancy.
    Holmberg E; Holm LE; Lundell M; Mattsson A; Wallgren A; Karlsson P
    Br J Cancer; 2001 Aug; 85(3):362-6. PubMed ID: 11487266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nationwide epidemiologic study of breast cancer incidence following breast reduction surgery in a large cohort of Swedish women.
    Fryzek JP; Ye W; Nyrén O; Tarone RE; Lipworth L; McLaughlin JK
    Breast Cancer Res Treat; 2006 May; 97(2):131-4. PubMed ID: 16328720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
    Tryggvadottir L; Sigvaldason H; Olafsdottir GH; Jonasson JG; Jonsson T; Tulinius H; Eyfjörd JE
    J Natl Cancer Inst; 2006 Jan; 98(2):116-22. PubMed ID: 16418514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
    Uusitalo E; Kallionpää RA; Kurki S; Rantanen M; Pitkäniemi J; Kronqvist P; Härkönen P; Huovinen R; Carpen O; Pöyhönen M; Peltonen S; Peltonen J
    Br J Cancer; 2017 Jan; 116(2):211-217. PubMed ID: 27931045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.